Should patients consider active surveillance?


  • Peter Albertsen MD

    Corresponding author
    1. Department of Urology, University of Connecticut Health Center, Farmington, Connecticut
    • Department of Urology, CT, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030
    Search for more papers by this author
    • Fax: (860) 679-1318;

  • See referenced original article on pages 2664–70, this issue.


The aging population, the widespread use of prostate-specific antigen testing, and the introduction of new genetic tests will continue to increase the number of incident cases of localized prostate cancer. Because many of these men harbor low-risk disease, clinicians seriously should consider offering an active surveillance protocol.